Due to the significant heterogeneity in case presentations, gaining a better understanding of ACE2 and TMPRSS2 immune pathways activated in different organ tissues on the background of varied pre-morbid states is a key component of understanding SARS-CoV2 pathophysiology and establishing ACE2-related therapies in the setting of severe infections. This evidence concerns the gene TMPRSS2 and infection.